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Primary extraosseous osteosarcomas (EOO) are very rare and extraosseous osteosarcoma 
of the parotid gland is even rarer. When they occur, EOO pursues a very aggressive cause. 
The consequence of the rarity of this malignancy and its aggressive course is that 
treatment guidelines are not yet standardized. We present a case of extraosseous 
osteosarcoma of the parotid gland we encountered in our practice 
 




Among all the various salivary glands, the parotid gland is the most commonly involved in 
neoplasm[1]. Despite this, primary malignant tumours of the parotid gland are still rare and 
there are several histological subtypes that can be seen in this gland[2]. 
Extra-skeletal or extraosseous osteosarcoma is an aggressive mesenchymal tumour that 
characteristically produce osteoid, bony or cartilaginous elements without clinical or 
radiological evidence of bone attachment at diagnosis[3]. Histological types described include 
osteoblastic, chondroblastic, fibroblastic, osteoclastic (Giant cell), telangiectatic, small cell (well 
differentiated) forms. Extraosseous osteosarcomas are relatively rare and involvement of the 
parotid gland by this tumour is even rarer[4]. Sarcomas affecting salivary glands commonly arise 
in a previously irradiated gland or in a background of a previous salivary gland tumour[5]. 
The prognosis of EOO is generally poor. Aside from the aggressive nature of this tumours[6, 7], 
thelate presentation is also a major contribution to the poor prognosis in our environment[8]. 
We present a case of extraosseous osteosarcoma of the parotid gland. 
Case Report 
The patient is a 46-year-old male trader with an 8-month history of left sided progressively 
increasing jaw swelling which was initially painless but became painful close to the time of 
presentation. The patient did not notice any change in the swelling with meal or change in  the 
overlying skin. He had no nasal, throat or ear complaints. There was no history of fever, weight 
loss or night sweat. The patient did not notice swelling in any other part of the body.  
He was a known hypertensive diagnosed 9 years prior to presentation and blood pressure was 
controlled and stable on anti-hypertensives. He was however not a known diabetic and had no 
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other known chronic medical condition. He has no history of head and neck irradiation. He had 
no family history of cancer and had never smoked tobacco or taken alcohol. 
 
Figure-1. Left side view of the patient showing the mass. 
 
 
Figure 2. Axial slice showing the parotid mixed density lesion with no involvement of the 
mandible. 
                                                                             
 Figure 3. (H&E X 200). The section from the mass shows numerous giant cells (upper part of 
the microphotograph) and osteoid (right lower corner) that are laid down by the proliferating 
malignant spindle cells. 
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Examination revealed a healthy looking man who was not in any distress. No physical evidence 
of pallor, dehydration, and jaundice. His temperature was normal. Cardiorespiratory 
examination findings were also essentially normal.  
He had a large left jaw mass 16cm x 14cm displacing the pinna cranially with normal overlying 
skin. The mass was hard, not tender and not differentially warm. It was fixed to underlying 
structures but not to skin. No intraoral extensions of the mass. No bruits heard over the mass 
and no neck masses. 
He had left facial nerve palsy (House-Brackmann I).   
Chest and abdominal examination were essentially normal. An FNAC of the Jaw swelling was 
reported as inflammatory. Chest X-ray and abdominal ultrasound are normal. 
Computerized Tomographic Scan of the region showed a large hypodense lesion in the left 
parotid region with areas of eggshell calcification. The mass extended into the deep lobe of the 
parotid. The ipsilateral temporal bone and the mandible showed no evidence of involvement. 
(Fig 1). 
A provisional diagnosis of the left benign parotid tumor to rule out malignancy was made. 
The patient had left Total Conservative Parotidectomy under general anaesthesia. 
Intraoperatively, we found a large 10cm x 6cm hard mass not distinct from the parotid. Mass is 
attached to the upper part of the ipsilateral sternocleidomastoid muscle and the lower division 
of the facial nerve. The post-operative period was uneventful. 
Histopathology of the mass showed tissue composed of proliferating malignant mesenchymal 
cells. These malignant cells are spindle shaped. Polyhedral, large cells are found intermixed 
within and in direct contact with lacelike and sheet- like osteoid of which is laid down by them. 
There are also numerous osteoclast-like multinucleated giant cells distributed throughout the 
tissue stroma. There are tumour giant cells as well as numerous mitotic figures. This finding 
suggested the histological diagnosis of osteosarcoma (Giant cell rich variant). Based on this 
report, the patient was referred to oncologists for chemo-radiation. 
He was free of local recurrence and distant metastasis 4 months post operation.  
Discussions 
We chose to report this case because of the extreme rarity of EOO occurring in the parotid 
gland.  To our knowledge, there are less than 5 reported cases of EOO of the parotid gland in 
literature  in the last 20 years.[4, 9] 
Osteogenic sarcoma is the commonest primary bone malignancy of young adults with several 
known histological subtypes including extraosseous variants[10]. Primary extraosseous 
osteosarcoma classically described as producing osteoid but devoid of attachment to bone[8].  
The distinction between benign and malignant parotid tumour seems to blur with regard to 
clinical presentations, our initial impression had to do with the relative rarity of malignant 
tumours of the parotid compared to other salivary glands[2]. Our miss with regards to the final 
diagnosis was not however influenced by the negative FNAC as we are fully aware of the 
implication of negative FNAC finding in patients with parotid gland tumours[11]. 
Our patient’s tumour was seen as a soft tissue mass with no bony attachments consistent with 
extraosseous osteosarcoma. However, benign parotid tumours too do not attach to the bone 
thus this knowledge did not help in reaching the final diagnosis. Extraosseous osteosarcoma 
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sometimes occurs in a background of previously existing neoplasia or following radiation 
exposure in 10% of cases [5].Our patient who had hitherto had been in excellent health with no 
previous irradiation. 
The peak age of occurrence has been found to be predominantly in middle-aged and older 
adults[6, 12] although there is a report in our environment of 3 patients out of 5 being under 20 
years old[8]. The age and sex of our patient are, however, consistent with what has been 
commonly reported from several centres[7, 13, 14]. 
This tumour is known to be very aggressive with a very high recurrence rate[6, 7]. Reports from 
several authors reveal a tendency toward early local recurrence within 2 years and a propensity 
for early metastasis. Our patient presented with a rapidly growing tumour suggestive of an 
aggressive tumour however our duration of follow-up is not enough to determine the possibly 
of local failure or not, there were, however, no evidence of distant metastasis. 
Generally, patients in our environment present late and this has often limited the options 
available to the surgeons. This was the experience of Alonge et al in which late presentation was 
reported to have contributed to the poor prognosis of their patients[8]. However, our index 
patient presented early though the part of the body affected, i.e. the parotid precluded biopsy 
that could have given us a pre-operative definitive diagnosis. We believe that this would have 
influenced the extent of the surgery especially with regards to sparing the facial nerve. 
We decided to use multimodal management in our patient due to the aggressive nature and the 
poor prognosis associated with the tumor. This decision was also based on the similar 
experience of other workers[9, 15].  
In conclusion, the extreme rarity of extraosseous osteosarcomas in the head and neck makes it 
important for reporting so that there can be enough knowledge base to understand this disease. 
It is important also for head and neck surgeons to be aware that osteosarcoma can occur in the 
salivary glands. Therefore, this tumour should be considered when confronted with an 
aggressive hard salivary gland tumour.    
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